Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematologyacute Myeloid Leukemia Working Group

Pinar, Ibrahim EthemCelik, SerhatPolat, Merve GokcenKaratas, Aylin FatmaDogan, AliIltar, UtkuSevindik, Omur Gokmen2025-05-102025-05-1020230006-49711528-002010.1182/blood-2023-187351https://doi.org/10.1182/blood-2023-187351https://hdl.handle.net/20.500.14720/15489Celik, Serhat/0000-0002-1052-9800; Atas, Unal/0000-0001-5897-6514; Kacmaz, Murat/0000-0003-1111-8605eninfo:eu-repo/semantics/openAccessIdarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematologyacute Myeloid Leukemia Working GroupConference Object142Q1Q1WOS:001159900803125